Design, synthesis, and in vitro evaluation of inhibitors of human leukocyte elastase based on a functionalized cyclic sulfamide scaffold
Date
2004-02-01Author
Zhong, Jiaying
Gan, Xiangdong
Alliston, Kevin R.
Groutas, William C.
Metadata
Show full item recordCitation
Bioorganic & medicinal chemistry. 2004 Feb 1; 12(3): 589-93.
Abstract
The design of novel functionalized templates capable of binding to the active site of serine proteases could potentially lead to the development of potent and highly selective non-covalent inhibitors of these enzymes. Using the elastase-turkey ovomucoid inhibitor complex and insights gained from earlier work based on the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold (I), a surrogate cyclosulfamide scaffold (II) was used for the first time in the design of reversible inhibitors of human leukocyte elastase. Compounds 7 and 8 were found to be micromolar reversible inhibitors of the enzyme.
Description
Full text of this article is not available in SOAR.